November 15, 2013 – New Orleans CityBusiness
CityBusiness is profiling the companies in the BioChallenge pitch competition. MiniVax is developing a treatment for a deadly fungal pneumonia that affects immunocompromised patients such as those suffering HIV/AIDs or those recovering from an organ transplant.
New Orleans BioInnovation Center granted funds to pilot diversity program in Life-Sciences Entrepreneurship Investment from JPMorgan Chase will help launch program in partnership with Xavier University of Louisiana NEW ORLEANS…
New technology revolutionizes DNA testing of sexual assault samples InnoGenomics SpermX™ delivers reliable results to solve sexual assault crimes NEW ORLEANS (March 28, 2023) – Addressing a long-term shortcoming in…
Local Biotech Company is Improving Clinical Care for Animals PetVet Dx celebrated recent expansion and future plans at a community event Friday NEW ORLEANS (March 31, 2023) Local biotech company…